Merck (LIM:MRK) FFO


LIM:MRK Merck & Co Inc LIM:MRK
73 GF Score
Price $120.00
GF Value $110.45
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Merck FFO?

FFO (Funds from operations) only applies to REITs.

LIM:MRK
73GF Score
Merck & Co Inc LIM:MRK
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Merck (LIM:MRK) Overvalued in 2026?

Based on GuruFocus' analysis, Merck stock appears to be overvalued. The current stock price of $120.00 is trading 8.6% above its estimated GF Value™ of $110.45. GuruFocus considers Merck to be Fairly Valued.

Key valuation signals for LIM:MRK:

  • FFO:
  • GF Value™: $110.45 vs. price of $120.00 (8.6% above fair value)
  • GF Score™: 73/100 with 7 warning signs

No single metric tells the full story. See the LIM:MRK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Merck Business Description

Address 126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
73GF Score

Get the complete analysis for LIM:MRK

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$120.00
Price
$110.45
GF Value